Regal Assets Analytics

GEO Investing

It’s ironic that company filings, earnings conference call transcripts, social media, letters to shareholders, data sources, and the internet have made it easier for investors to find InfoArb and use it to their advantage, but so many fail to do so. Why? Besides possibly not having a time to go through all these sources of information, now that more information is available than ever, it’s everywhere, so where do you start?

We find the conference call transcripts to be particularly valuable resources. It’s exciting to know that when companies report their quarterly earnings, the “accomplice” to great findings might be that not-so-well-attended live conference call. The call’s transcript will then reside on platforms like Seeking Alpha and Sentieo, which we happen to subscribe to.

Maj has a quick discussion with $CCEL CEO David Portnoy about current events going on at the company. CCEL provides private and public cord blood banking solutions for stem cell treatments. Specifically, David addressed questions on Revenue trends, Birth rate cause and effect on the company, Pricing environment, Expenditures and run rates, The company’s clinic plans, The shift in revenue expectations, FDA approval goals, Therapy pipeline